The American Journal of Managed Care > August 2013

The American Journal of Managed Care - August 2013

August 12, 2013 – Bitya Friedman, MD; Amnon Lahad, MD, MPH; Yizchak Dresner, MD, MS; and Shlomo Vinker, MD
This historical cohort study demonstrates that long-term statin use is associated with a significant decrease in the incidence of Parkinson's disease.
August 12, 2013 – Aviva G. Asnis-Alibozek, PA-C; Michael J. Fine, MD; Paul Russo, MD; Trent McLaughlin, BSc(Pharm), PhD; Eileen M. Farrelly, MPH; Norman LaFrance, MD; and William Lowrance, MD, MPH
Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.
August 12, 2013 – Ying Liu, PhD; Joseph E. Logan, PhD; Leonard J. Paulozzi, MD, MPH; Kun Zhang, MS; and Christopher M. Jones, PharmD
A quarter of opioid recipients with commercial insurance had at least 1 indicator of potential misuse by patients or inappropriate prescription practices by providers.
August 13, 2013 – Shou-Hsia Cheng, PhD; Chi-Chen Chen, PhD; and Chin-Hsiao Tseng, MD, PhD
Adherence to medication can improve healthcare outcomes but is associated with higher total healthcare expenses, especially during the years immediately following the onset of diabetes.
August 13, 2013 – Geoffrey D. Barnes, MD; Alexander Katz, MD; Jeffrey S. Desmond, MD; Steven L. Kronick, MD, MS; Jamie Beach, RN; Stanley J. Chetcuti, MD; Eric R. Bates, MD; and Hitinder S. Gurm, MD
Between 2005 and 2011, rates of cardiac catheterization laboratory false activation doubled while mean door-to-balloon times for primary PCI declined.
August 06, 2013 – Caroline S. Carlin, PhD; John Kralewski, PhD; and Megan Savage, BS
This article explores the information (scorecards, referrals, prior experience, location) influencing the choice of orthopedic surgeon and how this influence varies by patient characteristics.
August 06, 2013 – Mark W. Friedberg, MD, MPP; Anthony M. Buendia, BA; Katharine E. Lauderdale, BA; and Peter S. Hussey, PhD
By pricing options that protect providers from downside risk,health plans can more clearly evaluate different shared savings contracts and expand them to smaller providers.
August 06, 2013 – Natan R. Kahan, PhD, RPh, MHA; Daniel A. Vardy, MD, MSc; Dan-Andrei Waitman, MD, MPH; and Gherta Brill, MD
Sporadic, unsubstantiated side effects were reported in the mass media after a formulation change of levothyroxine tablets induced patients to monitor thyroid-stimulating hormone levels and to unnecessarily stop taking medication.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.